Prostate cancer screening has led to an increase in transrectal-ultrasonography (TRUS)-guided prostate biopsies. However, clinicians are becoming increasingly concerned that fluoroquinolone-resistant organisms are the cause of infectious complications in patients who have undergone this procedure. Two separate studies have shown that patients treated with fluoroquinolone prior to transrectal biopsy are at an increased risk of infectious complications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hodge, K. K., McNeal, J. E. & Stamey, T. A. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J. Urol. 142, 66–70 (1989).
Naughton, C. K., Miller, D. C., Mager, D. E., Ornstein, D. K. & Catalona, W. J. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J. Urol. 164, 388–392 (2000).
Nam, R. K. et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J. Urol. 183, 963–968 (2010).
Liss, M. A. et al. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J. Urol. 185, 1283–1288 (2011).
Wolf, J. S., Jr et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J. Urol. 179, 1379–1390 (2008).
Heidenreich, A. et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur. Urol. 59, 61–71 (2011).
Mosharafa, A. A., Torky, M. H., El Said, W. M. & Meshref, A. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology 78, 511–514 (2011).
Akduman, B. et al. Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology 78, 250–255 (2011).
Horcajada, J. P. et al. High prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol. Urology 74, 1195–1199 (2009).
Batura, D., Rao, G. G. & Nielsen, P. B. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJUI 106, 1017–1020 (2010).
Acknowledgements
I would like to thank Dr Ralph V. Clayman for his critical review of this manuscript.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Liss, M. Prostate biopsy—infection and prior fluoroquinolone exposure. Nat Rev Urol 8, 592–594 (2011). https://doi.org/10.1038/nrurol.2011.153
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2011.153
